Global  

Coronavirus vaccine trial by Moderna shows promising early results

Seattle Times Tuesday, 19 May 2020
The company said a test in eight healthy volunteers found its experimental vaccine was safe and provoked a strong immune response. It is on an accelerated timetable to begin larger human trials soon.
0
shares
ShareTweetSavePostSend
 
Video credit: WCVB - Published
News video: Moderna announces 'positive' early results in coronavirus vaccine trial

Moderna announces 'positive' early results in coronavirus vaccine trial 01:06

The vaccine candidate "has the potential to prevent COVID-19 disease," said Dr. Tal Zaks.

Related videos from verified sources

Greenville clinic selected to run COVID-19 vaccine trial [Video]

Greenville clinic selected to run COVID-19 vaccine trial

Vitalink Research was selected by Moderna to run the trial.

Credit: WYFF     Duration: 01:27Published
Inovio Pharmaceuticals COVID-19 Vaccine Shows Positive Early-Stage Test Results [Video]

Inovio Pharmaceuticals COVID-19 Vaccine Shows Positive Early-Stage Test Results

The company says it hopes to get data supporting the effectiveness of its COVID-19 vaccine early next year.

Credit: CBS 3 Philly     Duration: 00:53Published
WBZ News Update For June 12 [Video]

WBZ News Update For June 12

Weekend Weather; HHS Secretary At Beth Israel; NH Stay At Home Order Lifting; Moderna Vaccine Trial Update

Credit: WBZ CBS Boston     Duration: 02:08Published

Related news from verified sources

Coronavirus Vaccine Trial by Moderna Shows Promising Early Results

The company said its preliminary test in 8 healthy volunteers was safe. It is on an accelerated timetable to begin a larger human trial soon.
NYTimes.com Also reported by •SBSSeattle TimesProactive InvestorsReutersChicagoTribuneUSATODAY.comSeattlePI.comMotley FoolNewsy

Early results from Moderna vaccine trial show participants developed antibodies against coronavirus

Study subjects who received Moderna's COVID-19 vaccine had positive early results, according to the biotech company, which partnered with the National Institutes...
CTV News Also reported by •ChicagoTribuneUSATODAY.com

Moderna skyrockets 29% after its early trial for a coronavirus vaccine produced antibodies in all 45 patients (MRNA)

Moderna skyrockets 29% after its early trial for a coronavirus vaccine produced antibodies in all 45 patients (MRNA)
** · *Moderna announced on Monday that its early trial for its coronavirus vaccine produced antibodies in all patients. * · *Shares of the company surged...
Business Insider Also reported by •Proactive InvestorsReutersSeattle TimesSeattlePI.com

Tweets about this

rendheszvous

bea 🍉 RT @rapplerdotcom: This stage allows scientists to observe, using a large healthy population, whether the vaccine is more effective than a… 6 minutes ago

PHLNewsInsider

PHL News Insider RT @ABSCBNNews: Moderna Inc confirmed it plans to start a trial of 30,000 volunteers of its much-anticipated coronavirus vaccine in July as… 1 hour ago

dlivefeeds

TheLiveFeeds. com Covid-19 Moderna set to start final-stage trial of its coronavirus vaccine by July https://t.co/XOJAyW2ztB 3 hours ago

nottodaycovid19

Not Today COVID-19 PH Moderna, a US biotech company, will officially enter its final trial stage for a coronavirus vaccine in July 2020.… https://t.co/KqtjrvY02N 7 hours ago

birdy87

Lisa 🇬🇧❤️🇦🇺 | #loveconquerseverything RT @CNBC: JUST IN: Moderna plans to start its phase 3 coronavirus vaccine trial in July, @MegTirrell reports. https://t.co/kmuUkwHE0I https… 9 hours ago

CDDVault

Collaborative Drug Discovery Moderna Set to Test COVID-19 Vaccine in 30,000 People Starting in July https://t.co/QiRAHJOLq6 #DrugDiscovery #COVID19 #coronavirus 9 hours ago

PrinceOfMorroco

El Patron Marroqui ! 🇲🇦 🇦🇹🕵🏼 RT @CNBC: Moderna announced this morning that it plans to start its phase 3 coronavirus vaccine trial in July. @MegTirrell reports. https:/… 12 hours ago

kubrakkoc

Kübra Akkoç “Even in the best of times, developing a vaccine is an enormous technical challenge that pushes the frontiers of sc… https://t.co/dJXBn20Mqu 13 hours ago